These medical device companies provide the most research payments

这些医疗设备公司提供的研究费用最多

2020-02-01 04:00:08 Mass Device

本文共424个字,阅读需2分钟

That was a big takeaway from an analysis of Medical Design & Outsourcing‘s annual Big 100 and the most recent data available on CMS Open Payments. The world’s 20 biggest publicly-traded medtech companies made $159.9 million in research payments to doctors and teaching hospitals in 2018, spending an average of 0.1% of their annual revenue. On average, each company doled out 1.2% of its research and development spending to doctors and teaching hospitals in 2018. Medtronic topped the list with $64 million in research payments to doctors and teaching hospitals. Those payments were 2.7% of its R&D spending and 0.2% of its annual revenue in 2019. Research payments to doctors and teaching hospitals go toward research studies of certain devices from the company. Some studies are investigator-sponsored and evaluate the safety and efficacy of devices such as stents, leads, imaging devices and more. Here is a breakdown of how the 10 companies with the most payments divvied up their research payments between doctors and teaching hospitals — and what the top payments from each company went toward. A note on our methodology: We evaluated the top 20 publicly-traded medical device companies in the world based on annual revenue and listed in Medical Design & Outsourcing‘s annual Big 100 to decide which companies to include and took a look at the most recent data available on the CMS Open Payments website.
这是对医疗设计和外包年度大100的分析和 CMS 开放支付的最新数据的一个很大的好处。 2018年,全球20家最大的上市医药科技公司向医生和教学医院支付了1.599亿美元的研究费用,平均占其年收入的0.1%。平均而言,2018年每家公司将研发支出的1.2%分配给医生和教学医院。 美美敦力(Medtronic)公司以向医生和教学医院支付的研究费用高达6400万美元,位居榜首。这些支出占其研发支出的2.7%,占其2019年年度收入的0.2%。 支付给医生和教学医院的研究费用用于研究公司的某些设备。一些研究是由研究者发起的,并评估诸如支架、引线、成像设备等设备的安全性和有效性。 下面是10家支付最多的公司如何在医生和教学医院之间分配研究费用的细目,以及每家公司的最高支付金额。 方法说明:我们根据年度收入对全球20家上市医疗器械公司进行了评估,并在医疗设计与外包年度大100强中上市,以决定哪些公司应包括并查看 CMS 开放支付网站上最新的数据。

以上中文文本为机器翻译,存在不同程度偏差和错误;偶尔因源网页结构局限,内容无法一次完整呈现。请理解并参考原站原文阅读。

阅读原文